This document discusses Directly Observed Therapy (DOT) for tuberculosis treatment. DOT involves observing patients take their medications to ensure adherence and completion of treatment. It reduces the risk of drug resistance and relapse. The role of DOT providers is described, including delivering medications, observing ingestion, and documenting visits. Barriers to adherence like cultural and social factors are addressed, as are strategies to promote adherence through incentives, enablers, and addressing non-adherence when needed through legal means. The importance of DOT and treatment adherence is emphasized for treatment success and reducing transmission.